CERA in the spotlight for Alzheimer Disease

There has been increasing evidence that changes can be seen in the retina in patients with Alzheimer's Disease. The Centre for Eye Research Australia (CERA) published an article in Nature this week on the using retinal imaging as a potential biomarker for diagnosis and monitoring of patients with Alzheimer's disease using commercially available camera called the Metabolic Hyperspectral Retinal Camera (MHRC, Optina Diagnostics, Montreal, Canada). This camera can detect Amyloid Beta in the retina. Read the full article here

#AlzheimersDisease #Biomarkers #Retinalimaging

Featured Review
Tag Cloud